Mackenzie Financial’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.4K Buy
+11,400
New +$1.33M ﹤0.01% 1550
2025
Q4
Sell
-12,300
Closed -$26.4K 1766
2025
Q3
$26.4K Buy
+12,300
New +$1.01M ﹤0.01% 1678

Other funds holding MRK

Mackenzie Financial's MRK Position: Q2 2026 in Review

Mackenzie Financial reduced its Merck (MRK) stake by 5.7% in Q2 2026, selling an estimated $16.9M and leaving 2,373,431 shares worth $305M. The position accounts for 0.31% of the portfolio, ranked #61.

Mackenzie Financial first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $334M in Q4 2017. 3,836 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Mackenzie Financial held 2,373,431 shares of Merck worth $305M as of Q2 2026.
  • Mackenzie Financial sold 144,004 Merck shares in Q2 2026, an estimated $16.9M.
  • Merck made up 0.31% of Mackenzie Financial's portfolio in Q2 2026, its #61 holding.
  • Mackenzie Financial first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Mackenzie Financial's Merck position peaked at $334M in Q4 2017.
  • 3,836 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.